CD40 and neoplasm: Importantly for translation, we also showed that tumor debulking could be synergistic with immunotherapies delivered as immune-gene therapy (Mukherjee et al., 2001), via activating anti-CD40 (Khong et al., 2013; Khong et al., 2014) or by using neoantigen-based vaccination therapy (Fisher et al., 2014).